Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option

Immune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic optionImmune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option, Published online: 31 May 2018; doi:10.1038/s41388-018-0288-yImmune checkpoints PVR and PVRL2 are prognostic markers in AML and their blockade represents a new therapeutic option

Source: Oncogene - May 31, 2018 Category: Cancer & Oncology Authors: Hauke Stamm Felix Klingler Eva-Maria Grossjohann Jana Muschhammer Eik Vettorazzi Michael Heuser Ulrike Mock Felicitas Thol Gabi Vohwinkel Emily Latuske Carsten Bokemeyer Roman Kischel Cedric Dos Santos Sabine Stienen Matthias Friedrich Michael Lutteropp D Source Type: research